Diane Joseph-McCarthy is Senior Vice President, Discovery & Early Development at EnBiotix, with more than 17 years drug discovery and leadership experience in the pharmaceutical and biotechnology sector.

Before joining EnBiotix, she was an Associate Director in Infection Chemistry at AstraZeneca, where she led an innovative group of scientists with impact across the discovery value chain.  In this role, she initiated and led a global team, across three international sites, as part of a key capability build in Predictive Science.  This effort also involved managing several external collaborations.  She also either led or was a member of several task forces aimed at transforming Infection’s early portfolio.

Prior to that, Dr. Joseph-McCarthy was at Wyeth, as the Cambridge Site Head for Computational Chemistry, where she worked across therapeutic areas.  She has been actively involved in the discovery of several compounds that have reached clinical trials.  Dr. Joseph-McCarthy received her BA from Boston University, and her PhD from MIT with Professors Gregory A. Petsko and Martin Karplus (Nobel Laureate).  Following her dissertation, she was a Research Fellow at Harvard Medical School, with fellowships from the Radcliffe Bunting Institute, the Charles A. King Medical Foundation, and the Giovanni Armenise-Harvard Foundation.

Dr. Joseph-McCarthy has more than 65 publications and patents, and has given numerous invited talks.  She has served as a member of the National Academies of Sciences Polio Antiviral Advisory Committee, and is currently a member of the editorial advisory board for two international journals.